Physician

David Todd Goldenberg, MD

According to 2025 Medicare claims, David Goldenberg, MD (NPI: 1417170432) practices ophthalmology in the Phoenix-Mesa-Chandler, AZ market, with the plurality of this provider's patient population coming from Maricopa, AZ. This provider's primary affiliated billing organization is RETINAL CONSULTANTS OF ARIZONA LTD (NPI: 1700823051; TIN: 860708606) and primary practice location at 85260-8510.

Goldenberg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,860 traditional Medicare patients, billed 81,102 HCPCS/CPT codes, and received $5,521,090 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 889 prescription claims across 297 beneficiaries totaling $23,464 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 29 records totaling $1,463. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $43,246 to $23,464. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.9M$5.8M2015 Medicare payment: $4,820,925 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $5,771,015 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $5,736,560 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $5,409,895 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $5,504,368 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,361,881 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $5,259,110 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,922,987 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,754,777 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,521,090 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,82323,149$4,820,925
20161,80826,651$5,771,015
20171,89926,678$5,736,560
20182,01325,427$5,409,895
20191,99525,510$5,504,368
20201,73623,843$5,361,881
20211,74423,744$5,259,110
20221,71429,913$4,922,987
20231,72361,417$4,754,777
20241,86081,102$5,521,090

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$22K$44K2015 Drug cost: $43,246 (USD; Tot_Drug_Cst)2016 Drug cost: $41,496 (USD; Tot_Drug_Cst)2017 Drug cost: $43,629 (USD; Tot_Drug_Cst)2018 Drug cost: $37,819 (USD; Tot_Drug_Cst)2019 Drug cost: $31,718 (USD; Tot_Drug_Cst)2020 Drug cost: $33,927 (USD; Tot_Drug_Cst)2021 Drug cost: $31,788 (USD; Tot_Drug_Cst)2022 Drug cost: $25,141 (USD; Tot_Drug_Cst)2023 Drug cost: $24,326 (USD; Tot_Drug_Cst)2024 Drug cost: $23,464 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015240708$43,246
2016260745$41,496
2017298861$43,629
2018262711$37,819
2019241662$31,718
2020247677$33,927
2021272835$31,788
2022271822$25,141
2023257743$24,326
2024297889$23,464

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg3762,822$658
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more523523$117
67028Injection of drug into eye9473,274$95
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,0061,546$65
92134Imaging of retina1,7264,441$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate3799,115$10,287
MoxifloxacinMoxifloxacin Hcl1863,050$4,403
Ketorolac TromethamineKetorolac Tromethamine1453,133$3,150
Timolol MaleateTimolol Maleate672,215$375
OfloxacinOfloxacin32696$365

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.29$1,463Alimera Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David Todd Goldenberg, MD?

Tedicare shows public-source Medicare data for David Todd Goldenberg, MD (NPI 1417170432), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Todd Goldenberg, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Todd Goldenberg, MD?

David Todd Goldenberg, MD is linked to RETINAL CONSULTANTS OF ARIZONA LTD (billing NPI 1700823051) in the available physician profile data.

Does David Todd Goldenberg, MD have Open Payments data?

David Todd Goldenberg, MD has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.